Ivermectin in Peru – results that save lives
Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as a result of intensive ivermectin distribution. […]
Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as a result of intensive ivermectin distribution. […]
Further analysis of results from Peru has now shown that systematic treatment of the population for covid-19 with ivermectin resulted in a 14-fold reduction in excess deaths. IMI interviewed Dr […]
Retinoblastoma is a cancer that forms in the light-detecting cells in the back of the eye. It often appears in children under two years of age and can […]
Henry Ford physician, John Craig, M.D., is leading an international research effort to improve the multidisciplinary collaboration between otolaryngologists and dental providers around the globe when it comes […]
People who have had major sinus surgery should consult their ENT doctor before undergoing COVID-19 swab testing, new research indicates. Likewise, those performing swab testing should ask whether […]
Ivermectin is a good treatment to use interim to and complementary to immunisations, according to Dr David Scheim, one of the authors of a study of mass treatment for covid-19 […]
Dr David Scheim, one of the authors of a recent study in Peru, describes the doses of ivermectin that were used and the strategies for effective mass distribution. https://www.youtube.com/watch?v=MSkKU18VlNo […]
Mature, real world data on systematic mass treatment of covid-19 with ivermectin show a sharp fall in excess deaths. IMI interviewed Dr David Scheim, one of the authors […]
Delayed diagnoses and more patients with advanced cancers were consequences of the coronavirus pandemic, according to Dr Erin Schenk, Assistant Professor, Thoracic Oncology, University of Colorado. The coronavirus […]
Modern lung cancer treatment has changed the outlook for lung cancer patients considerably and interesting trial results are expected this year, according to Dr Erin Schenk, Assistant Professor, […]
Dr Erin Schenk, Assistant Professor, Thoracic Oncology, University of Colorado describes the results of the ADAURA trial and the implications for her practice. The other trial that has […]
IMI interviewed Dr Erin Schenk, Assistant Professor, Thoracic Oncology, University of Colorado to find out about key trial results in lung cancer and the implications for patient care. […]